67 related articles for article (PubMed ID: 8346467)
1. [Success of cyclosporine therapy in two patients with PSS].
Higuchi C; Sanaka T; Nihei H; Sugino N
Ryumachi; 1993 Jun; 33(3):242-8. PubMed ID: 8346467
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of oral methotrexate in the treatment of systemic sclerosis.
Krishna Sumanth M; Sharma VK; Khaitan BK; Kapoor A; Tejasvi T
Int J Dermatol; 2007 Feb; 46(2):218-23. PubMed ID: 17269983
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment of patients affected by systemic sclerosis with cyclosporin A.
Basso M; Filaci G; Cutolo M; Murdaca G; Derchi L; Gianrossi R; Ropolo F; Zentilin P; Sulli A; Puppo F; Indiveri F
Ann Ital Med Int; 2001; 16(4):233-9. PubMed ID: 11799631
[TBL] [Abstract][Full Text] [Related]
4. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
Colakoğlu M; Cobankara V; Akpolat T
Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
[TBL] [Abstract][Full Text] [Related]
5. [Cyclophosphamide pulse therapy for pediatric systemic sclerosis].
Iwata N; Miyamae T; Imagawa T; Katakura S; Mori M; Aihara Y; Yokota S; Kondo M; Sasaki T; Ikezawa Y
Ryumachi; 2003 Oct; 43(4):660-6. PubMed ID: 14598659
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine in the treatment of an unusual case of juvenile systemic sclerosis.
al-Mayouf SM; Silverman ED; Feldman BM; Thorner P; Laxer RM
J Rheumatol; 1998 Apr; 25(4):791-3. PubMed ID: 9558187
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of systemic scleroderma with D-penicillamine. Results in 14 patients treated for more than a year].
Kahn MF; Bourgeois P; Brion N; Elleuch M
Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):35-8. PubMed ID: 3704510
[TBL] [Abstract][Full Text] [Related]
8. Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis.
Rosato E; Letizia C; Proietti M; Aversa A; Menghi G; Rossi C; Torella E; Cotesta D; Petramala L; Bruzziches R; Spera G; Pisarri S; Salsano F
J Biol Regul Homeost Agents; 2009; 23(1):23-9. PubMed ID: 19321043
[TBL] [Abstract][Full Text] [Related]
9. Low versus high-dose iloprost therapy over 21 days in patients with secondary Raynaud's phenomenon and systemic sclerosis: a randomized, open, single-center study.
Kawald A; Burmester GR; Huscher D; Sunderkötter C; Riemekasten G
J Rheumatol; 2008 Sep; 35(9):1830-7. PubMed ID: 18634152
[TBL] [Abstract][Full Text] [Related]
10. [A patient with systemic scleroderma showing improvement during long-term hemodialysis after renal crisis].
Fuse Y; Muramatsu M; Sugiyama S; Maeda K
Ryumachi; 1997 Aug; 37(4):574-80. PubMed ID: 9311284
[TBL] [Abstract][Full Text] [Related]
11. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
Abou-Raya A; Abou-Raya S; Helmii M
J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
[TBL] [Abstract][Full Text] [Related]
12. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
Fries R; Shariat K; von Wilmowsky H; Böhm M
Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
[TBL] [Abstract][Full Text] [Related]
13. Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease.
Mittoo S; Wigley FM; Wise R; Xiao H; Hummers L
Arthritis Rheum; 2007 Dec; 56(12):4195-202. PubMed ID: 18050251
[TBL] [Abstract][Full Text] [Related]
14. Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based review.
Henness S; Wigley FM
Curr Opin Rheumatol; 2007 Nov; 19(6):611-8. PubMed ID: 17917543
[TBL] [Abstract][Full Text] [Related]
15. Improvement of progressive systemic sclerosis (PSS) with estriol treatment.
Katayama H; Ohsawa K; Yaoita H
Acta Derm Venereol; 1984; 64(2):168-71. PubMed ID: 6203310
[TBL] [Abstract][Full Text] [Related]
16. Efficacy evaluation of prostaglandin E1 against placebo in patients with progressive systemic sclerosis and significant Raynaud's phenomenon.
Bartolone S; Trifiletti A; De Nuzzo G; Scamardi R; Larosa D; Sottilotta G; Raffa A; Barbera N
Minerva Cardioangiol; 1999 May; 47(5):137-43. PubMed ID: 10479851
[TBL] [Abstract][Full Text] [Related]
17. Cyclofenil in the treatment of scleroderma - a general view on the results after treating 29 cases.
Bülow BB; Boström H; Herbai G; Persson B; Wollheim F; Oberg K
Z Rheumatol; 1980; 39(1-2):1-8. PubMed ID: 7424193
[TBL] [Abstract][Full Text] [Related]
18. Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study.
Khanna D; Yan X; Tashkin DP; Furst DE; Elashoff R; Roth MD; Silver R; Strange C; Bolster M; Seibold JR; Riley DJ; Hsu VM; Varga J; Schraufnagel DE; Theodore A; Simms R; Wise R; Wigley F; White B; Steen V; Read C; Mayes M; Parsley E; Mubarak K; Connolly MK; Golden J; Olman M; Fessler B; Rothfield N; Metersky M; Clements PJ;
Arthritis Rheum; 2007 May; 56(5):1676-84. PubMed ID: 17469162
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine A in treatment of membranous lupus nephropathy.
Hu W; Liu Z; Shen S; Li S; Yao X; Chen H; Li L
Chin Med J (Engl); 2003 Dec; 116(12):1827-30. PubMed ID: 14687467
[TBL] [Abstract][Full Text] [Related]
20. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.
Wigley FM; Korn JH; Csuka ME; Medsger TA; Rothfield NF; Ellman M; Martin R; Collier DH; Weinstein A; Furst DE; Jimenez SA; Mayes MD; Merkel PA; Gruber B; Kaufman L; Varga J; Bell P; Kern J; Marrott P; White B; Simms RW; Phillips AC; Seibold JR
Arthritis Rheum; 1998 Apr; 41(4):670-7. PubMed ID: 9550476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
